Hep Par 1 antibody stain for of hepatocellular carcinoma: The differential diagnosis 676 tumors tested using tissue microarrays and conventional tissue sections

被引:140
作者
Fan, Z [1 ]
de Rijn, MV [1 ]
Montgomery, K [1 ]
Rouse, RV [1 ]
机构
[1] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA
关键词
hepatocellular carcinoma; immunohistochemistry; hepatocyte paraffin 1; microarray;
D O I
10.1097/01.MP.0000052103.13730.20
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A well-characterized positive marker for hepatocellular differentiation would be a useful tool for the diagnosis of hepatocellular carcinoma (HCC). The recently commercially available Hep Par I antibody (clone OCH1E5.2.10) has been reported to be a sensitive marker for HCC in parafflin embedded sections. Of non-hepatocellular tumors, occasional carcinomas have been reported to stain, most frequently gastric adenocarcinomas. This study further evaluated the staining of this antibody on a large number of neoplasms using tissue microarray technology as well as conventional tissue sections. Six hundred seventy-six tumors, including 19 cases of HCC, were tested. Eighteen of 19 cases of HCC were positive, 3 showing <5% staining. Two cases negative on the array showed focal staining when whole tissue sections from the same tumors were used. 16 of 34 cases of gastric carcinomas gave positive reactions, 4 of these showed less than 5% staining. Staining of gastric carcinomas was not limited to signet ring-type carcinomas or to areas of hepatoid differentiation. Only 1 of 11 cases of cholangio-carcinoma showed focal staining. We also noted several other tumors to stain occasionally, including adrenal cortical carcinoma (3/13), yolk sac tumor (2/9), colonic adenocarcinoma (8/106), lung carcinoma (3/52), ovarian carcinoma (5/48), and endocervical. adenocarcinoma (1/5). We did not observe staining in pancreatic carcinoma (11), renal cell carcinoma (36), breast carcinoma (85), melanoma (25), or mesothelioma (5). This study supports Hep Par I as a useful marker in the differential diagnosis of HCC, but with significant limitations. Cautious use of this antibody in a panel with other positive (alpha fetoprotein, CD10, poly-clonal carcinoembryonic antigen) and negative (epithelial. membrane antigen, monoclonal carcinoembryonic antigen, CD15) markers of hepatocellular differentiation may aid in the accurate diagnosis of HCC.
引用
收藏
页码:137 / 144
页数:8
相关论文
共 18 条
[1]   DISTINCTION BETWEEN HEPATOCELLULAR-CARCINOMA, CHOLANGIOCARCINOMA, AND METASTATIC CARCINOMA BASED ON IMMUNOHISTOCHEMICAL STAINING FOR CARCINOEMBRYONIC ANTIGEN AND FOR CYTOKERATIN-19 ON PARAFFIN SECTIONS [J].
BALATON, AJ ;
NEHAMASIBONY, M ;
GOTHEIL, C ;
CALLARD, P ;
BAVIERA, EE .
JOURNAL OF PATHOLOGY, 1988, 156 (04) :305-310
[2]   Validation of tissue microarray technology in breast carcinoma [J].
Camp, RL ;
Charette, LA ;
Rimm, DL .
LABORATORY INVESTIGATION, 2000, 80 (12) :1943-1949
[3]   Hepatocyte antigen as a marker of hepatocellular carcinoma - An immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein [J].
Chu, PGG ;
Ishizawa, S ;
Wu, E ;
Weiss, LM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (08) :978-988
[4]   An evaluation of enzymatic and heat epitope retrieval methods for the immunohistochemical staining of the intermediate filaments [J].
Fan, Z ;
Clark, V ;
Nagle, RB .
APPLIED IMMUNOHISTOCHEMISTRY, 1997, 5 (01) :49-58
[5]  
Fasano M, 1998, MODERN PATHOL, V11, P934
[6]   IMMUNOHISTOCHEMICAL CHARACTERIZATION OF 130 CASES OF PRIMARY HEPATIC CARCINOMAS [J].
FERRANDEZIZQUIERDO, A ;
LLOMBARTBOSCH, A .
PATHOLOGY RESEARCH AND PRACTICE, 1987, 182 (06) :783-791
[7]   Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors [J].
Hoos, A ;
Urist, MJ ;
Stojadinovic, A ;
Mastorides, S ;
Dudas, ME ;
Leung, DHY ;
Kuo, D ;
Brennan, MF ;
Lewis, JJ ;
Cordon-Cardo, C .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (04) :1245-1251
[8]   IMMUNOHISTOCHEMISTRY IN THE DIFFERENTIAL-DIAGNOSIS OF LIVER CARCINOMAS [J].
HURLIMANN, J ;
GARDIOL, D .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1991, 15 (03) :280-288
[9]  
KOELMA IA, 1986, ARCH PATHOL LAB MED, V110, P1035
[10]   Tissue microarrays for high-throughput molecular profiling of tumor specimens [J].
Kononen, J ;
Bubendorf, L ;
Kallioniemi, A ;
Bärlund, M ;
Schraml, P ;
Leighton, S ;
Torhorst, J ;
Mihatsch, MJ ;
Sauter, G ;
Kallioniemi, OP .
NATURE MEDICINE, 1998, 4 (07) :844-847